Palbociclib-induced autophagy and senescence in gastric cancer cells

Claudio A Valenzuela1, Leandro Vargas1, Valentina Martinez1

  • 1Center for Medical Research, University of Talca School of Medicine, Avenida Lircay S/N, Talca, Chile.

Experimental Cell Research
|September 27, 2017
PubMed

Insights

CDK4/6 inhibitors like Palbociclib induce cellular senescence in gastric cancer cells. Autophagy acts as a survival mechanism, and its blockade exacerbates senescence, especially when p53 is present.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Targeting cyclin D-CDK4/6 kinase complexes improves survival in estrogen receptor-positive breast cancer.
  • CDK4/6 inhibitors are being investigated for other cancers with hyperactive cyclin D-CDK4/6 pathways.
  • Understanding cellular responses to CDK4/6 inhibition is crucial for expanding therapeutic use and overcoming resistance.

Purpose of the Study:

  • To investigate the sensitivity of gastric cancer cells to the CDK4/6 inhibitor Palbociclib.
  • To elucidate the cellular processes, including senescence and autophagy, induced by CDK4/6 inhibition in gastric cancer.
  • To determine the role of pRB and p53 status in mediating these cellular responses.

Main Methods:

  • Treatment of gastric cancer cells (AGS) with Palbociclib.
  • Assessment of cellular senescence induction.
  • Analysis of autophagy markers and autophagic flux.
  • Manipulation of p53 expression via knockdown.

Main Results:

  • Gastric cancer cells exhibit sensitivity to Palbociclib, leading to cellular senescence.
  • In p53 and pRB-expressing cells, Palbociclib induces both senescence and autophagy.
  • Simultaneous inhibition of CDK4/6 and autophagy worsens senescence, indicating autophagy's pro-survival role.
  • p53 knockdown reduces senescence and blocks autophagy, disrupting cargo degradation.

Conclusions:

  • CDK4/6 inhibition with Palbociclib is a potential therapeutic strategy for gastric cancer.
  • Autophagy functions as an adaptive survival mechanism in response to CDK4/6 inhibition in gastric cancer.
  • The p53 tumor suppressor protein plays a significant role in regulating both senescence and autophagy induction following CDK4/6 inhibition.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.3K